Once again, marijuana is in the spotlight. On December 18, 2025, President Trump signed Executive Order 14370 on expanding medical marijuana and cannabidiol (CBD) research, with the goal of rescheduling marijuana from a Schedule I drug to a Schedule III drug. Some may recall that the Biden Administration began taking similar steps in 2024. Continue reading for a brief discussion on the recent history of marijuana reclassification, what Executive Order 14370 accomplishes, and what considerations ...
Read More